Biotech, Cannabis, Food & Drug, & Pharma Law Updates

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Title
Publication Date Organization
Jun
6
2022
One Step Closer: N.C. Senate Passes Medical Cannabis Legislation
Jun
6
2022
New Prohibition of Vapes and Electronic Cigarettes in Mexico OLIVARES
Jun
6
2022
“Fudge” Pop-Tarts Claims Dismissed Keller and Heckman LLP
Jun
3
2022
Several State “Job Killer” Bills Move One Step Closer to Passage Proskauer Rose LLP
Jun
3
2022
False Advertising Suit Over “Smoked” Gouda Continues Keller and Heckman LLP
Jun
2
2022
FDA Resumes Routine Surveillance Inspections Foley & Lardner LLP
Jun
2
2022
Summer 2022 Is Here – Do You Know How the FDA User Fee Legislation Is Going? Mintz
Jun
2
2022
Counterfeit Dealer Gets Smoked in Trademark Preliminary Injunction Proceeding McDermott Will & Emery
Jun
1
2022
EPA Activates Emergency Viral Pathogen Guidance for Monkeypox Virus Bergeson & Campbell, P.C.
Jun
1
2022
Unpacking Averages: Violations Found in Medical Device Warning Letters Epstein Becker & Green, P.C.
Jun
1
2022
Getting into the Weeds: The Latest on the Alabama Medical Cannabis Program Bradley Arant Boult Cummings LLP
Jun
1
2022
Senate Bill to Revise and Reassess GRAS Program Keller and Heckman LLP
May
31
2022
Digital Health in the Metaverse: Three Legal Considerations Sheppard, Mullin, Richter & Hampton LLP
May
31
2022
Potential Pitfalls of Telehealth Prescribing Mintz
May
31
2022
SUNSET Rule Withdrawn Keller and Heckman LLP
May
27
2022
McDermottPlus Check-Up: May 27, 2022 McDermott Will & Emery
May
27
2022
Legal Protections for Food Safety Whistleblowers Katz Banks Kumin LLP
May
27
2022
FDA Issues Warning Letters to Four Companies Selling Unapproved CBD Products for Food-Producing Animals Keller and Heckman LLP
May
26
2022
Rhode Island Legalizes Recreational Marijuana and Protects Off-Duty Use Jackson Lewis P.C.
May
26
2022
FDA Webinar on Action Levels for Lead in Juice Keller and Heckman LLP
May
26
2022
ISO Publishes Standard on Characterization of CNT and CNF Aerosols for Inhalation Toxicity Tests Bergeson & Campbell, P.C.
May
26
2022
It's About Time: Federal Court Addresses Delta-8 Ward and Smith, P.A.
May
26
2022
Will FDA’s Proposed Ban on Flavored Tobacco Products Ever be Implemented?
May
25
2022
Connecticut Makes Significant Changes to its Collaborative Drug Therapy Laws Robinson & Cole LLP
May
25
2022
We Shouldn't Be Surprised the Massachusetts AG Is Doing to PFAS Manufacturers What a Prior AG Did to Tobacco Manufacturers but It's Still Notable! Mintz
May
25
2022
Medicare Advantage: OIG Report Finds Improper Denials
May
25
2022
Modifications to Proposition 65 Short-Form Warnings on Pause – New Regulatory Proposal to Come ArentFox Schiff LLP
May
25
2022
Pop-Tarts False Ad Lawsuit Permanently Dismissed Keller and Heckman LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins